Drug intelligence / Profile preview

Xufol

Development stage: Unknown
Lead developer: Zaiva Lifesciences
Modality: Small Molecules
Administration: Oral

Overview

**Xufol** is an oral fixed-dose nutritional vitamin combination marketed by Zaiva Lifesciences. Each tablet contains L-methylfolate, methylcobalamin, and pyridoxal 5-phosphate, the biologically active forms of folate, vitamin B12, and vitamin B6, respectively. It is used to replenish these vitamin deficiencies and support folate-dependent red blood cell formation and hemoglobin production.

Brand names: Xufol
Other names: L-methylfolate + methylcobalamin + pyridoxal 5-phosphate

Beyond the preview

Go deeper on Xufol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xufol.

Explore the full profile